Resumo
Definição
História e exame físico
Principais fatores diagnósticos
- previous VTE, thrombophilia, malignancy, postoperative setting, trauma, and indwelling central catheter
- chronic medical conditions, paresis, increasing age, obesity, estrogen-containing birth control pills and hormone replacement therapy, varicose veins, pregnancy and up to 6 weeks postpartum, first-degree relative with a history of VTE, extended travel, and admission to intensive care
Fatores de risco
- previous VTE (deep vein thrombosis [DVT] and/or pulmonary embolism [PE])
- thrombophilia
- malignancy
- postoperative setting
- trauma
- indwelling central catheter (upper or lower extremity)
- immobility
- myeloproliferative diseases
- congestive heart failure
- chronic obstructive pulmonary disease
- inflammatory bowel disease (IBD)
- neurologic disease with extremity paresis
- increasing age
- obesity
- use of estrogen-containing birth control pills, hormone replacement therapy (HRT), or androgen deprivation therapy
- history of varicose veins
- pregnancy/postpartum
- extended travel
- lower leg immobility
- first-degree relative with a history of VTE
- admission to intensive care
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- CBC
- serum creatinine
- INR
- PTT
Investigações a serem consideradas
- serum antiplatelet factor 4 antibodies
Algoritmo de tratamento
all at-risk patients
trauma patients
surgical patients
medical patients
Colaboradores
Autores
Anna L. Parks, MD
Assistant Professor
Division of Hematology
University of Utah
Salt Lake City
UT
Declarações
ALP declares that she has no competing interests.
Agradecimentos
Dr Anna L. Parks would like to gratefully acknowledge Dr Nathalie Routhier, Dr Vicky Tagalakis, Dr Farah Zarka, Dr Vincent Bouchard-Dechêne, and Dr Adi J. Klil-Drori, previous contributors to this topic.
Declarações
NR, FZ, VBD, and AJKD declare no competing interests. VT has received honoraria from BMS Pfizer and Bayer. She has developed educational materials for Thrombosis Canada. VT is an author of references cited in this topic.
Revisores
Andrew Parfitt, MBBS, FFAEM
Clinical Director
Acute Medicine
Associate Medical Director
Consultant Emergency Medicine
Guy's and St Thomas' NHS Foundation Trust
Clinical Lead and Consultant
Accident Emergency Medicine
St Thomas' Hospital
London
UK
Declarações
AP declares that he has no competing interests.
Sudeep Shivakumar, MD
Hematologist
Thrombosis Fellow
University of Ottawa
Ottawa Health Research Institute
Ottawa
Canada
Declarações
SS declares that he has no competing interests.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(suppl 2):e227S-77S.Texto completo Resumo
Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141(2 Suppl):e278S-325.Texto completo Resumo
Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012 Feb;141 (2 Suppl):e195S-226S.Texto completo Resumo
National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. Aug 2019 [internet publication].Texto completo
Nicolaides AN, Fareed J, Spyropoulos AC, et al. Prevention and management of venous thromboembolism. International consensus statement (guidelines according to scientific evidence). Int Angiol. 2024 Feb;43(1):1-222.Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diretrizes
- NCCN clinical practice guidelines in oncology: cancer-associated venous thromboembolic disease
- Venous thromboembolism in cancer patients: ESMO clinical practice guideline
Mais DiretrizesFolhetos informativos para os pacientes
Deep vein thrombosis
DVT and long-distance travel
Mais Folhetos informativos para os pacientesVideos
Venepuncture and phlebotomy: animated demonstration
Mais vídeosConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal